Cargando…

Cationic Geminoid Peptide Amphiphiles Inhibit DENV2 Protease, Furin, and Viral Replication

Dengue is an important arboviral infectious disease for which there is currently no specific cure. We report gemini-like (geminoid) alkylated amphiphilic peptides containing lysines in combination with glycines or alanines (C(15)H(31)C(O)-Lys-(Gly or Ala)(n)Lys-NHC(16)H(33), shorthand notation C(16)...

Descripción completa

Detalles Bibliográficos
Autores principales: Damen, Mark, Izidoro, Mario A., Okamoto, Debora N., Oliveira, Lilian C. G., Amatdjais-Groenen, Helene I. V., van Dongen, Stijn F. M., van Cleef, Koen W. R., van Rij, Ronald P., Dieteren, Cindy E. J., Gironés, Daniel, van Buuren, Bernd N. M., Martina, Byron E. E., Osterhaus, Albert D. M. E., Juliano, Luiz, Scholte, Bob J., Feiters, Martin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143577/
https://www.ncbi.nlm.nih.gov/pubmed/35630694
http://dx.doi.org/10.3390/molecules27103217
Descripción
Sumario:Dengue is an important arboviral infectious disease for which there is currently no specific cure. We report gemini-like (geminoid) alkylated amphiphilic peptides containing lysines in combination with glycines or alanines (C(15)H(31)C(O)-Lys-(Gly or Ala)(n)Lys-NHC(16)H(33), shorthand notation C(16)-KX(n)K-C(16) with X = A or G, and n = 0–2). The representatives with 1 or 2 Ala inhibit dengue protease and human furin, two serine proteases involved in dengue virus infection that have peptides with cationic amino acids as their preferred substrates, with IC(50) values in the lower µM range. The geminoid C(16)-KAK-C(16) combined inhibition of DENV2 protease (IC(50) 2.3 µM) with efficacy against replication of wildtype DENV2 in LLC-MK2 cells (EC(50) 4.1 µM) and an absence of toxicity. We conclude that the lysine-based geminoids have activity against dengue virus infection, which is based on their inhibition of the proteases involved in viral replication and are therefore promising leads to further developing antiviral therapeutics, not limited to dengue.